These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34806679)

  • 1. Renal Denervation in the treatment of Resistant Hypertension.
    Yap LB; Balachandran K
    Med J Malaysia; 2021 Nov; 76(6):893-897. PubMed ID: 34806679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
    Weber MA; Mahfoud F; Schmieder RE; Kandzari DE; Tsioufis KP; Townsend RR; Kario K; Böhm M; Sharp ASP; Davies JE; Osborn JW; Fink GD; Euler DE; Cohen DL; Schlaich MP; Esler MD
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1095-1105. PubMed ID: 31221299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
    Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
    J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.
    Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M
    Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Denervation in the Management of Resistant Hypertension: A Comprehensive Review of Literature.
    Salehin S; Karnkowska B; Hamza I; Malik H; Syeda D; Hasan SM; Rangasetty U; Gilani S; Jneid H; Raja M
    Curr Probl Cardiol; 2024 Feb; 49(2):102137. PubMed ID: 37863457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal arteries denervation with second generation systems: a remedy for resistant hypertension?
    Versaci F; Sciarretta S; Scappaticci M; Calcagno S; di Pietro R; Sbandi F; Dei Giudici A; Del Prete A; de Angelis S; Biondi-Zoccai G
    Eur Heart J Suppl; 2020 Nov; 22(Suppl L):L160-L165. PubMed ID: 33239993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
    Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
    Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P; Cremer A; Kirtane AJ; Lobo MD; Saxena M; Daemen J; Wang Y; Stegbauer J; Weber MA; Abraham J; Kario K; Bangalore S; Claude L; Liu Y; Azizi M
    Hypertension; 2021 Feb; 77(2):529-536. PubMed ID: 33356403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
    Kario K; Mahfoud F; Kandzari DE; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Brar S; Hettrick DA; Fahy M; Böhm M
    Hypertens Res; 2023 Jan; 46(1):280-288. PubMed ID: 36241705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y
    EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    Fengler K; Höllriegel R; Okon T; Stiermaier T; Rommel KP; Blazek S; Besler C; von Roeder M; Petzold M; Schuler G; Lurz P
    J Hypertens; 2017 Jun; 35(6):1310-1317. PubMed ID: 28441700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in renal denervation devices for resistant hypertension treatment.
    Haribabu S; Sharif F; Zafar H
    Ir J Med Sci; 2021 Aug; 190(3):971-979. PubMed ID: 33111251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M; Mahfoud F; Townsend RR; Kandzari DE; Pocock S; Ukena C; Weber MA; Hoshide S; Patel M; Tyson CC; Weil J; Agdirlioglu T; Fahy M; Kario K
    Eur Heart J; 2019 Mar; 40(9):743-751. PubMed ID: 30608521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
    Kario K; Ogawa H; Okumura K; Okura T; Saito S; Ueno T; Haskin R; Negoita M; Shimada K;
    Circ J; 2015; 79(6):1222-9. PubMed ID: 25912693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation.
    Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
    Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.